Sino Medical Sciences Technology Inc. (SHA:688108)
China · Delayed Price · Currency is CNY 21.30
+1.80 (9.23%)
May 15, 2026, 11:29 AM CST
SHA:688108 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 68.78 | 47.29 | 1.5 | -39.63 | -162.38 | -130.77 |
Depreciation & Amortization | 73.99 | 73.99 | 78.16 | 62.81 | 63.17 | 65.41 |
Other Amortization | 19.77 | 19.77 | 24.39 | 24.55 | 24.11 | 15.48 |
Loss (Gain) From Sale of Assets | - | - | -0.29 | 1.41 | -0 | -0.19 |
Asset Writedown & Restructuring Costs | 0.07 | 0.07 | 0.09 | 0.14 | 2.22 | 0.08 |
Loss (Gain) From Sale of Investments | - | - | -11.19 | 4.67 | 4.11 | 0.29 |
Provision & Write-off of Bad Debts | 0.27 | 0.27 | -0.43 | -1.41 | 1.33 | -0.54 |
Other Operating Activities | 10.94 | 10.77 | 18.47 | 5.37 | 6.78 | 11.62 |
Change in Accounts Receivable | -16.59 | -16.59 | 10.31 | 18.86 | 7.73 | 100.12 |
Change in Inventory | 4.14 | 4.14 | 18.7 | -14.53 | -18.38 | -27.79 |
Change in Accounts Payable | 0.21 | 0.21 | 0.34 | 3.03 | 8.04 | -59.48 |
Change in Other Net Operating Assets | 0.99 | 0.99 | 3.27 | 7.62 | - | - |
Operating Cash Flow | 183.54 | 161.87 | 131.24 | 56.84 | -111.31 | -60.13 |
Operating Cash Flow Growth | 27.00% | 23.34% | 130.89% | - | - | - |
Capital Expenditures | -40.07 | -45.8 | -70.02 | -67.67 | -110.76 | -158.45 |
Sale of Property, Plant & Equipment | 0.03 | 0.03 | 0.83 | 1.39 | 0.02 | 0.66 |
Cash Acquisitions | - | - | -20.35 | -127.05 | - | -25.84 |
Investment in Securities | - | - | - | - | 21.19 | -5 |
Other Investing Activities | - | - | 0.07 | 0.29 | 0.62 | 2.04 |
Investing Cash Flow | -40.04 | -45.77 | -89.46 | -193.04 | -88.93 | -186.59 |
Short-Term Debt Issued | - | - | - | - | 55.5 | 5 |
Long-Term Debt Issued | - | 67.4 | 81 | 159.5 | - | - |
Total Debt Issued | 134.44 | 67.4 | 81 | 159.5 | 55.5 | 5 |
Short-Term Debt Repaid | - | - | - | - | -25 | - |
Long-Term Debt Repaid | - | -119.4 | -93.79 | -44.68 | -16.2 | -14.4 |
Total Debt Repaid | -205.35 | -119.4 | -93.79 | -44.68 | -41.2 | -14.4 |
Net Debt Issued (Repaid) | -70.91 | -52 | -12.79 | 114.82 | 14.3 | -9.4 |
Issuance of Common Stock | 89.61 | 11.53 | 15.38 | - | 103.5 | - |
Common Dividends Paid | -3.98 | -4.19 | -4.11 | -2.01 | -0.94 | -0.03 |
Other Financing Activities | -65.75 | 34.91 | 62.99 | 9.5 | - | - |
Financing Cash Flow | -51.03 | -9.74 | 61.47 | 122.32 | 116.86 | -9.43 |
Foreign Exchange Rate Adjustments | -1.56 | -1.64 | -0.21 | -0.9 | -0.95 | -0.75 |
Net Cash Flow | 90.91 | 104.73 | 103.03 | -14.78 | -84.33 | -256.91 |
Free Cash Flow | 143.47 | 116.07 | 61.22 | -10.83 | -222.07 | -218.58 |
Free Cash Flow Growth | 115.99% | 89.59% | - | - | - | - |
Free Cash Flow Margin | 25.42% | 22.09% | 13.35% | -3.16% | -115.15% | -112.46% |
Free Cash Flow Per Share | 0.31 | 0.27 | 0.16 | -0.03 | -0.55 | -0.54 |
Cash Income Tax Paid | 53.15 | 53.15 | 29.68 | 22.67 | -3.27 | 1.14 |
Levered Free Cash Flow | 105.35 | 81.95 | 95.15 | -29.66 | -162.62 | -163.59 |
Unlevered Free Cash Flow | 108.31 | 85.1 | 98.66 | -27.31 | -161.02 | -162.22 |
Change in Working Capital | 9.71 | 9.71 | 20.55 | -1.07 | -50.64 | -21.52 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.